Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation

被引:20
|
作者
Caritis, Steve N. [1 ]
Simhan, Hyagriv N. [1 ]
Zhao, Yuan [16 ]
Rouse, Dwight J. [2 ,3 ]
Peaceman, Alan M. [4 ]
Sciscione, Anthony [5 ]
Spong, Catherine Y. [17 ]
Varner, Michael W. [6 ]
Malone, Fergal D. [7 ]
Iams, Jay D. [8 ]
Mercer, Brian M. [9 ]
Thorp, John M., Jr. [10 ]
Sorokin, Yoram [11 ]
Carpenter, Marshall [12 ]
Lo, Julie [13 ]
Ramin, Susan M. [14 ]
Harper, Margaret [15 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA
[2] Univ Alabama Birmingham, Dept Obstet, Med Sch Birmingham, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Gynecol, Med Sch Birmingham, Birmingham, AL USA
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[5] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[6] Univ Utah, Sch Med, Salt Lake City, UT USA
[7] Columbia Univ, Coll Phys & Surg, New York, NY USA
[8] Ohio State Univ, Ohio State Coll Med, Cleveland, OH USA
[9] Case Western Reserve Univ, Sch Med, Metrohlth Med Ctr, Cleveland, OH USA
[10] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[11] Wayne State Univ, Sch Med, Detroit, MI USA
[12] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
[13] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[14] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
[15] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
[16] George Washington Univ, Ctr Biostat, Washington, DC USA
[17] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
关键词
17-hydroxyprogesterone caproate; pharmacodynamics; twin gestation; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; PREMATURITY; PREVENTION;
D O I
10.1016/j.ajog.2012.08.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. STUDY DESIGN: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed. RESULTS: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P < .001). Women receiving 17-OHPC demonstrated significantly higher (P = .005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P < .0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group. CONCLUSION: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] LACK OF ANDROGENICITY OF 17-HYDROXYPROGESTERONE OR ITS 17-CAPROATE ESTER
    GOLDZIEHER, JW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1957, 17 (02): : 323 - 325
  • [22] Is 17α-hydroxyprogesterone caproate contraindicated in twin gestations?
    Romero, R.
    Conde-Agudelo, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (01) : 6 - 7
  • [23] Novel 17-Hydroxyprogesterone caproate metabolite in maternal and cord blood
    Stout, Molly J.
    Fujiwara, Hideji
    Salama, Noha N.
    Ory, Daniel
    Cahill, Alison G.
    Macones, George A.
    Tuuli, Methodius G.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S408 - S409
  • [24] Metabolism of 17-hydroxyprogesterone caproate by human hepatic and placental microsomes
    Yan, Ru
    Nanovskaya, Tatiana
    Mattison, Donald
    Hankins, Gary D. V.
    Ahmed, Mahmoud
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) : S48 - S48
  • [25] 17-Hydroxyprogesterone Caproate for Twin Pregnancy: A Double-Blind, Randomized Clinical Trial EDITORIAL COMMENT
    Combs, C. Andrew
    Garite, Thomas
    Maurel, Kimberly
    Das, Anita
    Porto, Manuel
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2011, 66 (07) : 393 - 394
  • [26] Fetal fibronectin and cervical length as predictors of preterm birth in twin pregnancies, with or without 17-hydroxyprogesterone caproate
    Combs, C. Andrew
    Garite, Thomas
    Maurel, Kimberly
    Das, Anita
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S205 - S205
  • [27] Evaluating the change in distribution of gestational age at delivery with the initiation of 17-alpha-hydroxyprogesterone caproate at an urban institution
    Bastek, Jamie A.
    Adamczak, Joanna E.
    Elovitz, Michal A.
    Srinivas, Sindhu K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S194 - S194
  • [28] The Effect of 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth on Cervicovaginal IL-6 Concentrations
    Schubert, Frank P.
    Gianopoulos, John G.
    Hoppensteadt, Debra A.
    REPRODUCTIVE SCIENCES, 2011, 18 (03) : 315A - 315A
  • [29] 17-Hydroxyprogesterone caproate reverses thromboxane induced vasoconstriction of the fetoplacental arteries
    Paonessa, D
    Shields, A
    Celver, J
    Howard, B
    Gotkin, J
    Deering, S
    Hoeldtke, N
    Napolitano, P
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (06) : S59 - S59
  • [30] Effect of Federal Regulation on Compounding of 17-hydroxyprogesterone Caproate in North Carolina
    Hoopes, Sarah
    Nitsche, Joshua F.
    OBSTETRICS AND GYNECOLOGY, 2017, 129 : 139S - 139S